- Home
- DSS vs CNSP Comparison
DSS vs CNSP Comparison
Compare DSS & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DSS | CNSP |
|---|---|---|
| Founded | 1984 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3M | 7.3M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | DSS | CNSP |
|---|---|---|
| Price | $0.56 | $4.53 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | ★ 2.9M | 26.6K |
| Earning Date | 05-15-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.45 | 8.03 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,085,000.00 | N/A |
| Revenue This Year | $1.21 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.36 | $0.73 |
| 52 Week High | $1.90 | $10.59 |
Technical Indicators
Market Signals| Indicator | DSS | CNSP |
|---|---|---|
| Relative Strength Index (RSI) | 50.22 | 46.43 |
| Support Level | $0.36 | $4.50 |
| Resistance Level | $1.05 | $5.61 |
| Average True Range (ATR) | 0.13 | 0.31 |
| MACD | 0.01 | -0.10 |
| Stochastic Oscillator | 27.77 | 19.05 |
Price Performance
Historical ComparisonAbout DSS DSS Inc.
DSS Inc is operating a business focused on four operating segments: Product Packaging, Biotechnology, Commercial Lending, and Securities and Investment Management. Currently operates five distinct business lines that operate around the globe with primary operations in North America and Asia. Product packaging manufactures and sells sophisticated custom folding cartons, mailers, photo sleeves, and complex three-dimensional direct mail solutions. The biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the Securities and Investment Management.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.